Trial intelligence / Profile preview

Paracetamol vs Ibuprofen for Patent Ductus Arteriosus in Premature Infants

NCT04037514Phase 3Completed

Start
Jul 2017
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms). Primary endpoint: Rate of closure of the hsPDA. Started Jul 2017; status: completed.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on NCT04037514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04037514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call